Delivery Order SPE2DB20D3103-SPE2DB23FL6U9

Award Date 11/22/22
Potential Completion Date 11/23/22
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,206.40 firm-fixed-price contract is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML, a specialty pharmaceutical product. The order has a completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML, a medical product used for diabetes management. The contract has a ceiling value of $41,682.05 and a period of performance through November 21, 2023. This contract is a firm fixed price delivery order issued under...
This federal contract award, valued at $2,371.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML, a critical medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,474.68 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML, a critical medical commodity used in the treatment of diabetes. The contract has an ultimate completion date of May 1, 2024 and was awarded on April 30, 2024. This delivery order is part of a larger $999,999,999...
This federal contract award, with a ceiling value of $26,133.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML medical supplies, with a performance period ending on January 17, 2024. This contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated with any set-aside requirements, indicating...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,245.58, is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL. The contract is a Firm Fixed Price type and has an ultimate completion date of December 18, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/ML Pen 3ML. The contract is a firm fixed price delivery order with a ceiling value of $6,144.50 and a period of performance through August 20, 2024. The award is not associated with a set-aside designation, indicating open competition. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,610.83 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML medical products. The contract has an ultimate completion date of December 26, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4558564147 - Insulin Aspart 100 Unit/mL Pen 3mL. The contract has a firm fixed price of $8,635.43 and an ultimate completion date of September 23, 2022. This award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML, a critical diabetes medication, with a ceiling value of $15,385.76 and a period of performance through February 2024. The contract is firm-fixed price and was not set aside for any specific business size or type. Amerisourcebergen...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FL6U9
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,433.76, is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. The award supports critical medical commodities for federal healthcare programs, including military treatment facilities, veterans' healthcare, and other federal medical institutions.

Generated 2/27/25, 11:37 AM